Opioid-Sparing Versus Opioid-Based Analgesia for Craniotomy: A Multicenter Randomized Controlled Trial

INTRODUCTION: Pain control remains a challenge after neurosurgery. Opioid-sparing analgesia may provide better pain relief without opioid-related side effects after craniotomy. We aimed to compare analgesia requirement and postoperative pain between opioid-sparing and opioid-based analgesia for craniotomy. METHODS: This investigator-initiated, multicenter randomized controlled trial was conducted at 5 Indian centers from October 19, 2022, to September 5, 2024, in adult patients undergoing elective craniotomy for brain tumors, following trial registration (CTRI/2022/09/045705, September 20, 2022). Patients received fentanyl 1 µg.kg-1.h-1 or dexmedetomidine 0.5 µg.kg-1.h-1 in a 1:1 allocation ratio after anesthetic induction until dural closure as the primary systemic analgesic. In addition, patients received intraoperative loco-regional analgesia. Our primary outcomes were intraoperative rescue opioid consumption and incidence of moderate-to-severe pain on the numerical rating scale (NRS) in the postanesthesia care unit (PACU). Secondary outcomes were pain on the first 2 postoperative days, drug-associated harms, recovery profile, patient satisfaction, quality of sleep, hospital stay duration, and persistent pain at 3 and 6 months. RESULTS: There was no difference between fentanyl (n=252) and dexmedetomidine (n=248) groups for rescue fentanyl (38.0±63.1 vs. 44.6±81.7 μg, P=0.327) or moderate-to-severe pain in the PACU (145/242 vs. 138/233, P=0.559). Intraoperative hypotension was more common with dexmedetomidine (100/248 vs. 75/252, P=0.015), while shivering was lower than with fentanyl (9/241 vs. 22/251, P=0.026). Other outcomes were similar between groups. CONCLUSIONS: Both opioid-based and opioid-sparing regimens were similar regarding rescue analgesia, postoperative pain, and other in-hospital outcomes in patients undergoing craniotomy. Dexmedetomidine increased the occurrence of intraoperative hypotension and reduced postoperative shivering compared with fentanyl.

Authors

Institutions

Publication Details

Journal
Journal of Neurosurgical Anesthesiology
Published
2026-09-04
DOI
https://doi.org/10.1097/ana.0000000000001163
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Opioid-Sparing Versus Opioid-Based Analgesia for Craniotomy: A Multicenter Randomized Controlled Trial

Kamath Sriganesh, Padmaja Durga, Srilata Moningi, Smita Vimala et al.
Journal of Neurosurgical Anesthesiology
Anesthesia and Pain Management
article

Opioid-Sparing Versus Opioid-Based Analgesia for Craniotomy: A Multicenter Randomized Controlled Trial

Kamath Sriganesh, Padmaja Durga, Srilata Moningi, Smita Vimala, V. T. Jissa, Srinivasan Swaminathan, Keta Thakkar, Prasanna U. Bidkar, Venkataramaiah Sudhir, Georgene Singh, NOPAIN Collaborators, Manikandan Sethuraman
article en

Abstract

INTRODUCTION: Pain control remains a challenge after neurosurgery. Opioid-sparing analgesia may provide better pain relief without opioid-related side effects after craniotomy. We aimed to compare analgesia requirement and postoperative pain between opioid-sparing and opioid-based analgesia for craniotomy. METHODS: This investigator-initiated, multicenter randomized controlled trial was conducted at 5 Indian centers from October 19, 2022, to September 5, 2024, in adult patients undergoing elective craniotomy for brain tumors, following trial registration (CTRI/2022/09/045705, September 20, 2022). Patients received fentanyl 1 µg.kg-1.h-1 or dexmedetomidine 0.5 µg.kg-1.h-1 in a 1:1 allocation ratio after anesthetic induction until dural closure as the primary systemic analgesic. In addition, patients received intraoperative loco-regional analgesia. Our primary outcomes were intraoperative rescue opioid consumption and incidence of moderate-to-severe pain on the numerical rating scale (NRS) in the postanesthesia care unit (PACU). Secondary outcomes were pain on the first 2 postoperative days, drug-associated harms, recovery profile, patient satisfaction, quality of sleep, hospital stay duration, and persistent pain at 3 and 6 months. RESULTS: There was no difference between fentanyl (n=252) and dexmedetomidine (n=248) groups for rescue fentanyl (38.0±63.1 vs. 44.6±81.7 μg, P=0.327) or moderate-to-severe pain in the PACU (145/242 vs. 138/233, P=0.559). Intraoperative hypotension was more common with dexmedetomidine (100/248 vs. 75/252, P=0.015), while shivering was lower than with fentanyl (9/241 vs. 22/251, P=0.026). Other outcomes were similar between groups. CONCLUSIONS: Both opioid-based and opioid-sparing regimens were similar regarding rescue analgesia, postoperative pain, and other in-hospital outcomes in patients undergoing craniotomy. Dexmedetomidine increased the occurrence of intraoperative hypotension and reduced postoperative shivering compared with fentanyl.

Journal of Neurosurgical Anesthesiology
Nizam's Institute of Medical Sciences (IN), Christian Medical College, Vellore (IN), Sree Chitra Thirunal Institute for Medical Sciences and Technology (IN), European Society of Anaesthesiology (BE), Jawaharlal Institute of Post Graduate Medical Education and Research (IN), National Institute of Mental Health and Neurosciences (IN)
Good health and well-being
Openalex Percentile: Top 8%
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.